These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33960690)
21. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145 [TBL] [Abstract][Full Text] [Related]
22. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database. Afify AY; Ashry MH Eur Arch Otorhinolaryngol; 2024 Aug; 281(8):4409-4417. PubMed ID: 38775833 [TBL] [Abstract][Full Text] [Related]
23. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy. Mukhtar F; Ilozumba M; Utuama O; Cimenler O JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714 [TBL] [Abstract][Full Text] [Related]
24. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors. Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850 [TBL] [Abstract][Full Text] [Related]
25. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma. Mahjoub H; Loya A; Ayaz T; Weng CY Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336 [TBL] [Abstract][Full Text] [Related]
26. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis. Jiang S; Zhen H; Jiang H Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411 [TBL] [Abstract][Full Text] [Related]
27. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer. Yang J; Wu F; An H; Gan H Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483 [TBL] [Abstract][Full Text] [Related]
28. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis. Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302 [TBL] [Abstract][Full Text] [Related]
29. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study. Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548 [TBL] [Abstract][Full Text] [Related]
30. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107 [TBL] [Abstract][Full Text] [Related]
31. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis. Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751 [TBL] [Abstract][Full Text] [Related]
32. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465 [TBL] [Abstract][Full Text] [Related]
33. Increased risk of second primary cancers after a diagnosis of melanoma. Bradford PT; Freedman DM; Goldstein AM; Tucker MA Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496 [TBL] [Abstract][Full Text] [Related]
34. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018. Yang Z; Liu L; Leng K; Shi G J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675 [TBL] [Abstract][Full Text] [Related]
35. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study. Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769 [TBL] [Abstract][Full Text] [Related]
37. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. Morris LG; Sikora AG; Patel SG; Hayes RB; Ganly I J Clin Oncol; 2011 Feb; 29(6):739-46. PubMed ID: 21189382 [TBL] [Abstract][Full Text] [Related]
38. Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis. Banner L; Rohan TZ; Zachian R; Gross T; Yang HY; Joffe D; Porcu P; Nikbakht N J Am Acad Dermatol; 2024 Jul; 91(1):151-153. PubMed ID: 38513830 [No Abstract] [Full Text] [Related]
39. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018. Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220 [TBL] [Abstract][Full Text] [Related]
40. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study. Abdel-Rahman O Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]